Codebase Investment Adds Oral Mucosal Patent Filing, Expanding Transdermal Treatments Pharmaceutical Investing
Datametrex Awarded $217,000 by Department of National Defence for Completion of Phase 2 of Innovation Program Emerging Technology Investing
Conscience Capital Announces Completion of Qualifying Transaction with Hashoff, LLC Emerging Technology Investing
A2Z Technologies Canada Corp. to Present at the Planet MicroCap Showcase Virtual Investor Conference 2020 Defense And Security Investing
InsuraGuest Now Licensed to Sell Insurance in 47 US States, Including California and Florida Fintech Investing
Datametrex Provides Update On Health Canada Submission & Welcomes Advisors Emerging Technology Investing
Hydroxychloroquine Side Effects Potentially Mitigated by Transdermal Delivery Pharmaceutical Investing
A2Z Technologies Canada Believes TSXV Listing Will Help Future Product Development Emerging Technology Investing
CB2 Insights Completes Purchase of Colorado-based Relaxed Clarity with Surpassed Initial Targets and Provides Additional Corporate Updates Data Investing
Syntholene Completes Phase One of Effects Testing at Iceland Demonstration Facility, Advances to High-Power Operations
